temozolomide has been researched along with salvianolic acid a in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, R; Wang, Y; Wei, H; Xu, Y; Ye, T; Zhang, J; Zhang, Y; Zhang, Z; Zhou, Y | 1 |
1 other study(ies) available for temozolomide and salvianolic acid a
| Article | Year |
|---|---|
Salvianolic acid A (Sal A) suppresses malignant progression of glioma and enhances temozolomide (TMZ) sensitivity via repressing transgelin-2 (TAGLN2) mediated phosphatidylinositol-3-kinase (PI3K) / protein kinase B (Akt) pathway.
Topics: Brain Neoplasms; Caffeic Acids; Cell Line, Tumor; Glioma; Humans; Lactates; Microfilament Proteins; Muscle Proteins; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phosphatidylinositols; Proto-Oncogene Proteins c-akt; Signal Transduction; Temozolomide | 2022 |